Mirtazapine Relon Chem (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which increases the release of norepinephrine. It also antagonizes postsynaptic 5‑HT2 and 5‑HT3 receptors, enhancing serotonergic transmission while reducing certain serotonin‑related side effects. This dual action raises overall norepinephrine and serotonin activity in the brain, contributing to its antidepressant effect.

The specific dose of mirtazapine is individualized by the prescribing clinician based on the patient’s clinical condition, response, and tolerability. Typical adult regimens start at a low dose and may be adjusted upward, but the exact strength and schedule should be determined by a qualified healthcare professional.

Safety data for mirtazapine during pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

The most common alternative class for depression is selective serotonin reuptake inhibitors (SSRIs). Unlike SSRIs, mirtazapine increases both norepinephrine and serotonin by blocking α2‑adrenergic receptors and specific serotonin receptors, which often results in stronger sedative and appetite‑stimulating effects. Choice between them depends on individual symptom profile, side‑effect tolerance and clinician judgment.

Mirtazapine Relon Chem should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging to protect them from moisture and light. Do not store in areas of high humidity or direct sunlight, and keep out of reach of children.

The medication is taken orally, usually once daily in the evening because of its sedative effect. It can be swallowed with or without food, but patients should follow the specific instructions provided by their prescriber. Swallow tablets whole; do not crush or chew unless directed by a healthcare professional.

Serious risks include the emergence or worsening of suicidal thoughts, especially during the initial weeks of therapy, and rare blood disorders such as agranulocytosis or severe neutropenia. Severe allergic reactions, including Stevens‑Johnson syndrome, and significant hepatic dysfunction are also possible. Patients should seek immediate medical attention if they notice any of these symptoms.

Mirtazapine is contraindicated in patients who have a known hypersensitivity to the drug or any of its excipients. It should be avoided in individuals currently taking monoamine oxidase inhibitors (MAOIs) or who have taken an MAOI within the past 14 days. Caution is also advised for patients with severe hepatic impairment or uncontrolled epilepsy.